Why the study?
Despite guideline-based indications, women are less frequently treated with ICDs than men, and whether sex-related differences in ventricular arrhythmias have remained stable across implantation periods in routine practice was uncertain.
Does female sex reduce the risk of appropriate ICD therapy and mortality in adults undergoing de novo ICD implantation compared to male sex?
Cohort (n=2,184)
Yes
Does female sex reduce the risk of appropriate ICD therapy and mortality in adults undergoing de novo ICD implantation compared to male sex?
Answers are grounded in this paper and cite their sources.
While women receiving ICDs have lower unadjusted rates of appropriate therapy and mortality than men, these differences are attenuated after multivariable adjustment, suggesting they reflect underlying clinical substrate rather than sex alone.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Papa et al. (2026) conducted a cohort in Patients undergoing de novo ICD implantations (n=2,184). Male sex vs. Female sex was evaluated on Appropriate ICD therapy within 60 months after implantation (OR 1.27, 95% CI 0.94-1.73, p=0.12).
Synapse has enriched 10 related papers. Consider them for comparative context: